Programpunkter

The Nordic region is a strong market for digital health, due to the advanced healthcare systems, technological infrastructure and culture of innovation. With a focus on innovation, prevention, precision medicine and a strong research ecosystem, the Nordics offer fertile ground for digital health solutions to improve healthcare delivery, empower patients, and address the growing burden of chronic diseases. This session is a great opportunity to get to know the Nordic healthcare systems and their possibilities, challenges and why the Nordic market is a great fit for you!

At A great pitch@vitalis, the most innovative Healthtech companies will showcase new digital solutions in healthcare. Attendees can listen to short pitches where 10 companies present their innovations, followed by questions from a distinguished panel. We welcome you to join us for this engaging event with high energy and excitement!

Germany is Sweden’s most important trade partner. With its 84 million inhabitants, Germany provides wide reaching business potentials, not least within healthcare and specifically e-health. It is hence not surprising that this business area is a part of our two countries’ official innovation partnership, and that more and more Swedish companies have their sight set on Germany.During this ”German hour”, we will provide you with insights into the prerequisites of the German market, Germany’s new e-health strategy as well as the ongoing work with the so called DiGas (digital health apps). Furthermore, we present you with the opportunity to listen to an innovative Swedish e-health company that has taken its first steps into the German market and gladly shares their experiences with you.A warm willkommen to Germany!
The German market: prerequisites and structure, trends and potentialNinni Löwgren Tischer, Head of Division Market Entry & Business Development, German-Swedish Chamber of Commerce (AHK Schweden)The German e-health strategy and its DiGa-system: how it works and what business opportunities it presents Swedish innovation companies Dr. Lars Hunze, Deputy Head of Department for gematik, telematic infrastructure and eHealth, German Federal Ministry for Health (BMG)Case: Experiences, insights and reflections from a Swedish company that has taken its first steps into the German marketAnders Murman, Co-founder and CEO, DeversifyQ&A and a summary from a German-Swedish perspective addressing the challenges, common denominators and possible cooperationsNinni Löwgren Tischer, Head of Division Market Entry & Business Development, German-Swedish Chamber of Commerce (AHK Schweden)

Innovativa digitala lösningar blir alltfler och finns inom de flesta sjukdomsområden. Men hur kan pharma och tech-industrin (PharmaTech) samarbeta med sjukvården för att påskynda en jämlik introduktion?

Who winns the Healthtech Award 2024? Welcome to the award ceremony where the winner will be presented! More information to follow

What role can entrepreneurs, intrapreneurs and startups play in the future of healthcare? How can we promote collaboration?Panel discussion och mingle.
Square One Stockholm is a network that connects people who want to transform healthcare through innovation. https://www.linkedin.com/company/square-one-network/

The Nordic region is a strong market for digital health, due to the advanced healthcare systems, technological infrastructure and culture of innovation. With a focus on innovation, prevention, precision medicine and a strong research ecosystem, the Nordics offer fertile ground for digital health solutions to improve healthcare delivery, empower patients, and address the growing burden of chronic diseases. This session is a great opportunity to get to know the Nordic healthcare systems and their possibilities, challenges and why the Nordic market is a great fit for you!

Digital Health investments have significantly dropped from the peak of 2021. Many founders face challenges in fundraising, and there is an increase in internal bridge rounds. What does the global digital health investment landscape look like? How are the Nordic countries doing?

Luminar Ventures is an early stage tech investor with several companies in the e-health segment including, Mindler, Health Integrator, Vården.se and Yazen. With this talk I would like to describe how we as early stage investors view the healthcare system and industry in Sweden, what we see needs to be done to improve on innovation that aims to improve quality, access, conditions for healthcare workers, personalized care and more.

Explore the world of Digital Therapeutics (DTx) in the presentation, "DTx: From Concept to Market." I'll cover key aspects such as cost considerations, time-to-market strategies, regulatory compliance (including MDR), technology challenges, and European reimbursement schemes. The audience will gain insights to navigate the DTx landscape efficiently and effectively. 

Innovations to improve health are driven cross sectors. In our region we have a strong commitment from multiple sectors to drive this. A session where these comes together is what I propose as for Vitalis 2024.

Are you curious about the inner workings of biobanks and eager to learn more? Developed by EIT Health in collaboration with BBMRI-ERIC, this course is ideal for anyone interested in, studying or working in healthcare. Access our portal, you will find profiles of biobanks and health data registries from across Europe, highlighting their characteristics, specialties, and available samples or datasets. Whether you are searching for specific samples, genetic information, or other health-related data, our platform will guide you towards the relevant sources and facilitate access to these resources.

Denna föreläsning belyser hur MDR, EU AI Act och EU Health Data Space formar landskapet för medicinteknisk programvara. Vi utforskar de centrala utmaningarna, potentialen för innovation och hur vårdgivare samt företag kan navigera i denna komplexa regleringsmiljö.

Vi vill guida er genom Läkemedelsverkets spännande innovationsstödjande verksamhet, där vi strävar efter att uppfylla vårt uppdrag att stödja den svenska life science-sektorn. Vårt fokus ligger på tre huvudaktiviteter: Information och utbildning, vetenskaplig och regulatorisk rådgivning samt implementering av regulatorisk vetenskap.

Hälsodatavägledningen på halsodata.se ska vägleda innovationsprojekt till att nå sin fulla potential genom att drivas av användningsfall och förhålla sig till juridik, semantik och det befintliga ekosystemet av hälsodata. Den ska vägleda förbi de vanligaste hindren och genom tips på vägar framåt få initiativet att nå sin fulla potential. 

Vården behöver fler effektiva lösningar som hjälper patienterna till bättre hälsa. Därför går Sveriges sju universitetssjukhus med omgivande innovationskontor och inkubatorer in med sin samlade kapacitet i projektet Snabbare Implementering i Svensk Hälso- och Sjukvård (Siish). Målet är att avsevärt förkorta tiden för införandet av innovationer i vården. I presentationen får vi höra erfarenheter och lärorika resultat som hittills kommit från projektet.

Kvantdatorer står på tröskeln till att revolutionera hälsosektorn. Denna presentation tar en djupgående titt på kvantdatorers roll i hälsosektorn, från molekylär nivå till utveckling av nya behandlingar, precisionsmedicin och patientsäkerhet.Men vad är kvantdatorer egentligen, och när kan vi förvänta oss att de kommer påverka vår vardag? Detta föredrag demystifierar kvantdatorer med hjälp av enkelhet, humor och liknelser. Vi utforskar kvantdatorernas potential i utvecklingen av nya behandlingar och kvantdatorernas förmåga att hantera komplexa beräkningar så som molekylsimuleringar. Vi diskuterar också när det kan vara lämpligt att implementera denna banbrytande teknik, inte bara inom industrin utan också ur ett patientsäkerhetsperspektiv - där kvantdatorer utgör mer hot än hopp.

Breaking the waves – accelerating health innovation. 
Welcome to an afternoon that will help you unlock your global business potential!

Artificial Intelligence has become the way of exceeding beyond the human limitations and healthcare faces a new era of technology. The potential for AI-based medical devices is immense, but a challenging field to navigate. This presentation, based on a recent empirical study, gives insight on the common challenges faced by companies developing AI medical devices, and provide strategies on how to effectively overcome these challenges.